Legalization of cannabis for recreational and medicinal use in Canada and the U.S. has allowed big pharmaceutical companies to capitalize on the industry through cannabis patents and distribution . As of 2019 , Novartis had the largest number of patents among all cannabis patent holders in Canada . With over 21 patents for cannabis they were far above even the second ranked company , Pfizer , which had just 14 patents at that time .
